TuHURA Biosciences, Inc. (HURA): EPS (Diluted)
-$0.63
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.63 | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$1.21 | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$2.47 | n/c | 2025-03-31, From 2023-01-01 |
| No annual figure between 2015-06-30 and 2023-12-31. | |||
| 2015-06-30 | $0.11 | n/a | 2015-11-16, From 2014-07-01 |
| 2014-06-30 | $0.00 | n/a | 2015-11-16, From 2013-07-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| TuHURA Biosciences, Inc. (HURA) | 2025-12-31 | -$0.63 | n/m |
| Abbott Laboratories (ABT) | 2025-12-31 | $3.72 | -51.3% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $3.46 | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$0.05 | n/m |
| Eli Lilly & Co (LLY) | 2025-12-31 | $22.95 | +96.0% |
| Pfizer Inc (PFE) | 2025-12-31 | $1.36 | -3.5% |
| Johnson & Johnson (JNJ) | 2025-12-28 | $11.03 | +90.5% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $1.06 | +165.0% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $7.28 | +8.0% |
Compare HURA, ABT, BMY, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗